In-treatment assessment of response in locally advanced NSCLC: paving the way for personalized medicine.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Lung Cancer

• Publication date

  2014-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.lungcan.2014.10.006PMID 25454200
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Differential 18F-FDG and 18F-FLT Uptake on Serial PET/CT Imaging Before and During Definitive Chemoradiation for Non–Small Cell Lung Cancer

  2014cited by this paper
• Metabolic activity measured by FDG PET predicts pathological response in locally advanced superior sulcus NSCLC.

  2014cited by this paper
• 18F-FDG PET Early Response Evaluation of Locally Advanced Non–Small Cell Lung Cancer Treated with Concomitant Chemoradiotherapy

  2013cited by this paper
• Early response to chemotherapy in patients with non-small-cell lung cancer assessed by [18F]-fluoro-deoxy-D-glucose positron emission tomography and computed tomography.

  2013cited by this paper
• Response Assessment Using 18F-FDG PET Early in the Course of Radiotherapy Correlates with Survival in Advanced-Stage Non–Small Cell Lung Cancer

  2012cited by this paper
• Role of 18F-FDG PET in Assessment of Response in Non–Small Cell Lung Cancer

  2009cited by this paper

• Necessity of strengthening the current clinical regulatory for companion diagnostics: An institutional comparison of the FDA, EMA, and MFDS

  2023cites this paper
• Wilcoxon rank-sum tests to detect one-sided mixture alternatives in group sequential clinical trials

  2023cites this paper
• Pharmaceutical Product Modularization as a Mass Customization Strategy to Increase Patient Benefit Cost-Efficiently

  2021cites this paper
• Proteomics and personalized medicine: a focus on kidney disease

  2019cites this paper
• Making multi-omics data accessible to researchers

  2019cites this paper
• Designing one-sided group sequential clinical trials to detect a mixture alternative

  2018cites this paper
• From art to science: a new epistemological status for medicine? On expectations regarding personalized medicine

  2017cites this paper
• A Perspective on Implementing a Quantitative Systems Pharmacology Platform for Drug Discovery and the Advancement of Personalized Medicine

  2016cites this paper
• Expressiveness and instrumentality in homicide: hybrid crime scenes and the links among situations, psychological processes, and actions.

  2016cites this paper
• Nanotechnology for protein delivery: Overview and perspectives.

  2016cites this paper
• Integrating cardiomyocytes from human pluripotent stem cells in safety pharmacology: has the time come?

  2016cites this paper
• Personalized Cardiovascular Medicine Today: A Food and Drug Administration/Center for Drug Evaluation and Research Perspective.

  2015cites this paper
• The FDA and 23andMe: violating the First Amendment or protecting the rights of consumers?

  2014cites this paper